FDA Inspection
Labcorp Early Development Laboratories, Inc.Labcorp Early Development Laboratories, Inc. – FDA Inspection, Jul 25, 2025
Record Details
This FDA Inspection record concerns Labcorp Early Development Laboratories, Inc., with an inspection on July 25, 2025, issued by the Detroit District Office, covering human drugs.
- Inspection Date
- July 25, 2025
- Product Type
- Human Drugs
View Company Profile
ID · bd268f96-1ca7-420a-a020-53f7b5b8e1a8
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1276600
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
4- 21 CFR 211.68(b)Computer control of master formula records
- 21 CFR 211.160(b)Scientifically sound laboratory controls
- 21 CFR 211.192Investigations of discrepancies, failures
- 21 CFR 211.166(a)(4)Testing in same container - closure system
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Labcorp Early Development Laboratories, Inc.
4| Date | Classification | Office | Project area |
|---|---|---|---|
| April 11, 2025 | VAI | Detroit District Office | Bioresearch Monitoring: Human Drugs |
| July 12, 2024 | VAI | Detroit District Office | Bioresearch Monitoring |
| November 21, 2019 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 20, 2016 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Labcorp Early Development Laboratories, Inc.
- FDA Inspection 1266550 - 2025-04-11
- FDA Inspection 1243623 - 2024-07-12
- FDA Inspection 1113166 - 2019-11-21
- FDA Inspection 963103 - 2016-01-20
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.